Maravai LifeSciences To Host Earnings Conference Call on Thursday, February 22, 2024
Maravai LifeSciences, Inc. (MRVI) will announce its Q4 and full year 2023 financial and operating results on February 22, 2024. The company is a global provider of life science reagents and services to researchers and biotech innovators. A conference call and webcast will be hosted on the same day at 2:00 p.m. PT/ 5:00 p.m. ET.
01/29/2024 - 08:00 AM
SAN DIEGO, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its fourth quarter and full year 2023 financial and operating results after the market closes on Thursday, February 22, 2024, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET.
To participate in the conference call by telephone, dial (888) 596-4144 or (646) 968-2525 and reference Maravai LifeSciences, Conference ID 4939675. The call will also be available via live or archived webcast on the "Investors" section of the Maravai web site at https://investors.maravai.com .
About Maravai
When will Maravai LifeSciences announce its Q4 and full year 2023 financial results?
Maravai LifeSciences will announce its Q4 and full year 2023 financial results on February 22, 2024.
What is the ticker symbol for Maravai LifeSciences?
The ticker symbol for Maravai LifeSciences is MRVI.
How can I participate in the conference call?
To participate in the conference call by telephone, dial (888) 596-4144 or (646) 968-2525 and reference Maravai LifeSciences, Conference ID 4939675.
Where can I access the webcast of the conference call?
The webcast of the conference call will be available on the 'Investors' section of the Maravai website at https://investors.maravai.com.
Maravai LifeSciences Holdings Inc
MRVI Rankings
#4968 Ranked by Stock Gains
MRVI Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Tags
Commercial Services, Miscellaneous Commercial Services
Country
US
City
San Diego
About MRVI
maravai lifesciences catalyzes the growth of successful, entrepreneurial life science companies by providing expertise, capital, processes and systems so that they can continue to serve scientists who are striving to improve human health. current maravai lifesciences portfolio companies provide enabling tools and services in the life sciences research and bioproduction industries that accelerate breakthrough discoveries in areas such as genomics, proteomics, and biotherapeutic development. maravai lifesciences was formed in march 2014 through a partnership with gtcr, a leading private equity firm. our mission is to build a transformative life sciences reagents company by acquiring outstanding businesses and accelerating their growth. since our founding, we have acquired four companies, each a leader in its market segment. vector laboratories has led the market for labeling and detection products used by researchers in immunohistochemistry, immunofluorescence and related techniques. tri
